Inventor · disambiguated record
Stephen Robert Wedge
Also filed as: WEDGE STEPHEN · WEDGE STEPHEN R · WEDGE STEPHEN ROBERT
1 granted patent·34 pending applications·6 citations·filing 2002–2017
29Inventor score
Top patents by PatentIndex Score
35 records- 0176US8129738B2Optoelectronic device with periodic grating microstructureBARNES WILLIAM L·Filed 2010·Granted Mar 6, 2012·6 cites·12 claims
- 0251US2010215773A1Use of Quinazoline Derivative ZD6474 Combined With Platinum Compounds and Optionally Ionising Radiation in the Treatment of Diseases Associated With Angiogenesis and/or Increased Vascular PermeabilityASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 0351US2010069398A1Combination therapyWEDGE STEPHEN ROBERT·Filed 2009·Application pending·0 cites
- 0447US2010130520A1Combination therapyWEDGE STEPHEN ROBERT·Filed 2009·Application pending·0 cites
- 0547US2010029673A1Therapeutic agents comprising an anti-angiogenic agent in combination with an src-inhibitor and their therapeutic useASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 0645US2006167027A1Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeabilityWEDGE STEPHEN R·Filed 2004·Application pending·0 cites
- 0742US2008242663A1Novel pyrimidine derivatives 698ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 0841US2010179142A1Cancer Combination Therapy Comprising AZD2171 and ZD1839WEDGE STEPHEN ROBERT·Filed 2009·Application pending·0 cites
- 0940US2010130519A1Combination therapy comprising azd2171 and azd6244 or mek-inhibitor iiWEDGE STEPHEN ROBERT·Filed 2008·Application pending·0 cites
- 1040US2010130493A1Combination of vegf receptor tyrosine kinase inhibitors for treatment of cancerWEDGE STEPHEN ROBERT·Filed 2009·Application pending·0 cites
- 1140US2012263802A1Use of Quinazoline Derivative ZD6474 Combined With Platinum Compounds and Optionally Ionising Radiation in the Treatment of Diseases Associated With Angiogenesis and/or Increased Vascular PermeabilityWEDGE STEPHEN ROBERT·Filed 2011·Application pending·0 cites
- 1239US2011086870A1Combination TherapyASTRAZENECA AB·Filed 2010·Application pending·0 cites
- 1339US2009325977A1Cancer combination therapy comprising azd2171 and imatinibWEDGE STEPHEN ROBERT·Filed 2009·Application pending·0 cites
- 1437US2006142316A1Combination therapyWEDGE STEPHEN R·Filed 2004·Application pending·0 cites
- 1536US2021322415A1Methods comprising fixed intermittent dosing of cediranibASTRAZENE CA AB·Filed 2017·Application pending·0 cites
- 1636US2012252826A1Combination TherapyWEDGE STEPHEN ROBERT·Filed 2011·Application pending·0 cites
- 1736US2006160775A1Combination therapyWEDGE STEPHEN R·Filed 2004·Application pending·0 cites
- 1835US2009176731A1Combination therapy of cancer with azd2171 and gemcitabineWEDGE STEPHEN ROBERT·Filed 2006·Application pending·0 cites
- 1934US2005043395A1Combination therapy comprising zd6474 and a taxaneASTRAZENECA AB·Filed 2002·Application pending·0 cites
- 2034US2008269261A1Combination of Zd6474 and PemetrexedRYAN ANDERSON JOSEPH·Filed 2006·Application pending·0 cites
- 2133US2006223815A1Therapeutic agents comprising an anti-angiogenic agent in combination with an src-inhibitor and their therapeutic useCURWEN JON O·Filed 2004·Application pending·0 cites
- 2233US2006167024A1Cancer combination therapy comprising azd2171 and zd1839WEDGE STEPHEN R·Filed 2004·Application pending·0 cites
- 2332US2005269578A1Optoelectronic devicesBARNES WILLIAM L·Filed 2003·Application pending·0 cites
- 2431US2008015205A1Cancer Combination Therapy Comprising Azd2171 and ImatinibWEDGE STEPHEN R·Filed 2005·Application pending·0 cites
- 2531US2008119479A1Combination Comprising Zd6474 And ImatinibWEDGE STEPHEN ROBERT·Filed 2005·Application pending·0 cites
- 2630US2008113039A1Combination TherapyWEDGE STEPHEN ROBERT·Filed 2005·Application pending·0 cites
- 2730US2005245549A1Combination of vegf receptor tyrosine kinase inhibitors for treatment of cancerWEDGE STEPHEN R·Filed 2003·Application pending·0 cites
- 2830US2011212978A1Combination of ZD6474 and PemetrexedASTRAZENECA AB·Filed 2010·Application pending·0 cites
- 2927US2012252827A1Combination of therapy comprising zd6474 and a taxaneWEDGE STEPHEN ROBERT·Filed 2011·Application pending·0 cites
- 3026US2008306094A1Combination of Azd2171 and PemetrexedWEDGE STEPHEN ROBERT·Filed 2006·Application pending·0 cites
- 3125US2011256240A1Combination TherapyWEDGE STEPHEN ROBERT·Filed 2010·Application pending·0 cites
- 3224US2005222183A1Combination of zd6474, an inhibitor of the vascular endothelial growth factor receptor, with radiotherapy in the treatment of cancerWEDGE STEPHEN R·Filed 2003·Application pending·0 cites
- 3323US2008200436A1Combination Comprising Zd6474 And An AntiandrogenWEDGE STEPHEN ROBERT·Filed 2005·Application pending·0 cites
- 3422US2007135462A1Combination therapyWEDGE STEPHEN R·Filed 2005·Application pending·0 cites
- 3522US2008125447A1Combination TherapyWEDGE STEPHEN ROBERT·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stephen Robert Wedge files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →